首页> 外文OA文献 >Identification of biology-based breast cancer types with distinct predictive and prognostic features : role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

【2h】

Identification of biology-based breast cancer types with distinct predictive and prognostic features : role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

机译：鉴定具有不同预测和预后特征的生物学基础乳腺癌类型：类固醇激素和HER2受体表达在新辅助蒽环类/紫杉烷类化学治疗患者中的作用

页面导航

著录项
相似文献
相关主题

著录项

作者
Darb-Esfahani Silvia; Loibl Sibylle; Müller Berit Maria; Roller Marc; Denkert Carsten; Komor Martina; Schlüns Karsten; Blohmer Jens Uwe; Budczies Jan; Gerber Bernd; Noske Aurelia; Du Bois Andreas; Weichert Wilko; Jackisch Christian; Dietel Manfred; Richter Klaus; Kaufmann Manfred; Minckwitz Gunter von;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy [J] . Silvia Darb-Esfahani, Sibylle Loibl, Berit M Muller, Breast Cancer Research . 2009,第5期

机译：鉴定具有明显预测和预后特征的生物学基础乳腺癌类型：类固醇激素和HER2受体表达在新辅助蒽环类/紫杉烷类化学治疗患者中的作用
2. Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy [J] . Liang Huang, Tianwen Chen, Canming Chen, World Journal of Surgical Oncology . 2013,第1期

机译：Phospho-p44 / 42和pAKT在以蒽环类为基础的新辅助化疗治疗的HER2阳性局部晚期乳腺癌患者中的预后和预测价值
3. The Predictive and Prognostic Role of Topoisomerase Hoc and Tissue Inhibitor of Metalloproteinases 1 Expression in Locally Advanced Breast Carcinoma of Egyptian Patients Treated With Anthracycline-based Neoadjuvant Chemotherapy [J] . Hala S. El Rebey, Hayam A. S. Aiad, Iman L. Abulkheir, Applied immunohistochemistry and molecular morphology: AIMM . 2016,第3期

机译：基于蒽环类新辅助化疗治疗埃及患者局部晚期乳腺癌中拓扑异构酶Hoc和金属蛋白酶1表达的组织抑制剂的预测和预后作用。
4. Clinical implications of HER-2 and p53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer [C] . World congress on breast diseases . 2008

机译：HER-2和P53在紫杉烷基和蒽环类新辅助化疗的乳腺癌中的临床意义
5. Identification of distinct gene expression signatures in histologically normal epithelium from patients with different breast cancer risk. [D] . Graham, Kelly A. 2010

机译：在具有不同乳腺癌风险的患者中，从组织学上正常的上皮中鉴定出独特的基因表达特征。
6. Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy [O] . Silvia Darb-Esfahani, Sibylle Loibl, Berit M Müller, 2009

机译：鉴定具有明显预测和预后特征的生物学基础乳腺癌类型：类固醇激素和HER2受体表达在新辅助蒽环类/紫杉烷类化学治疗患者中的作用
7. Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy [O] . Silvia Darb-Esfahani, Sibylle Loibl, Berit M Müller, 2009

机译：鉴定具有明显预测和预后特征的生物学基础乳腺癌类型：类固醇激素和HER2受体表达在新辅助蒽环类/紫杉烷类化学治疗患者中的作用

Identification of biology-based breast cancer types with distinct predictive and prognostic features : role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

著录项

相似文献

相关主题

期刊订阅